false 2023 Q3 --12-31 0001722969 23703 P3Y 0001722969 2023-01-01 2023-09-30 0001722969 us-gaap:CommonClassAMember 2023-11-09 0001722969 us-gaap:CommonClassBMember 2023-11-09 0001722969 2023-09-30 0001722969 2022-12-31 0001722969 us-gaap:CommonClassAMember 2023-09-30 0001722969 us-gaap:CommonClassAMember 2022-12-31 0001722969 us-gaap:CommonClassBMember 2023-09-30 0001722969 us-gaap:CommonClassBMember 2022-12-31 0001722969 2023-07-01 2023-09-30 0001722969 2022-07-01 2022-09-30 0001722969 2022-01-01 2022-09-30 0001722969 NXU:CommonStockClassAMember 2023-06-30 0001722969 NXU:CommonStockClassCMember 2023-06-30 0001722969 NXU:CommonStockClassBMember 2023-06-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001722969 us-gaap:RetainedEarningsMember 2023-06-30 0001722969 2023-06-30 0001722969 NXU:CommonStockClassAMember 2022-12-31 0001722969 NXU:CommonStockClassCMember 2022-12-31 0001722969 NXU:CommonStockClassBMember 2022-12-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001722969 us-gaap:RetainedEarningsMember 2022-12-31 0001722969 NXU:CommonStockClassAMember 2022-06-30 0001722969 NXU:CommonStockClassCMember 2022-06-30 0001722969 NXU:CommonStockClassBMember 2022-06-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001722969 us-gaap:RetainedEarningsMember 2022-06-30 0001722969 2022-06-30 0001722969 NXU:CommonStockClassAMember 2021-12-31 0001722969 NXU:CommonStockClassCMember 2021-12-31 0001722969 NXU:CommonStockClassBMember 2021-12-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001722969 us-gaap:RetainedEarningsMember 2021-12-31 0001722969 2021-12-31 0001722969 NXU:CommonStockClassAMember 2023-07-01 2023-09-30 0001722969 NXU:CommonStockClassCMember 2023-07-01 2023-09-30 0001722969 NXU:CommonStockClassBMember 2023-07-01 2023-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001722969 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001722969 NXU:CommonStockClassAMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockClassCMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockClassBMember 2023-01-01 2023-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001722969 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockClassAMember 2022-07-01 2022-09-30 0001722969 NXU:CommonStockClassCMember 2022-07-01 2022-09-30 0001722969 NXU:CommonStockClassBMember 2022-07-01 2022-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001722969 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001722969 NXU:CommonStockClassAMember 2022-01-01 2022-09-30 0001722969 NXU:CommonStockClassCMember 2022-01-01 2022-09-30 0001722969 NXU:CommonStockClassBMember 2022-01-01 2022-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001722969 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001722969 NXU:CommonStockClassAMember 2023-09-30 0001722969 NXU:CommonStockClassCMember 2023-09-30 0001722969 NXU:CommonStockClassBMember 2023-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001722969 us-gaap:RetainedEarningsMember 2023-09-30 0001722969 NXU:CommonStockClassAMember 2022-09-30 0001722969 NXU:CommonStockClassCMember 2022-09-30 0001722969 NXU:CommonStockClassBMember 2022-09-30 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001722969 us-gaap:RetainedEarningsMember 2022-09-30 0001722969 2022-09-30 0001722969 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001722969 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0001722969 NXU:ChargingStationEquipmentMember 2023-09-30 0001722969 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001722969 us-gaap:EquipmentMember 2023-09-30 0001722969 us-gaap:OfficeEquipmentMember 2023-09-30 0001722969 us-gaap:VehiclesMember 2023-09-30 0001722969 us-gaap:SoftwareDevelopmentMember 2023-09-30 0001722969 NXU:BatterySystemsAndComponentsSalesMember 2023-07-01 2023-09-30 0001722969 NXU:RetailChargingServicesMember 2023-07-01 2023-09-30 0001722969 NXU:ChargingStationEquipmentMember 2022-12-31 0001722969 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001722969 us-gaap:EquipmentMember 2022-12-31 0001722969 us-gaap:OfficeEquipmentMember 2022-12-31 0001722969 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001722969 us-gaap:VehiclesMember 2022-12-31 0001722969 us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001722969 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001722969 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001722969 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001722969 2022-01-01 2022-12-31 0001722969 2017-01-01 2017-12-31 0001722969 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2023-07-01 2023-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2022-07-01 2022-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2023-01-01 2023-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2022-01-01 2022-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2023-07-01 2023-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2022-07-01 2022-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2023-01-01 2023-09-30 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2022-01-01 2022-09-30 0001722969 us-gaap:StockOptionMember 2023-07-01 2023-09-30 0001722969 us-gaap:StockOptionMember 2022-07-01 2022-09-30 0001722969 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001722969 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001722969 NXU:CommonStockClassBMember srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001722969 NXU:PublicOfferingMember 2023-02-01 2023-02-21 0001722969 NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:SeriesAWarrantsMember NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:SeriesBWarrantsMember NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:PublicOfferingMember 2023-08-01 2023-08-11 0001722969 NXU:PublicOfferingMember 2023-08-11 0001722969 NXU:GEMGlobalMember us-gaap:CommonClassAMember 2022-09-01 2022-09-27 0001722969 NXU:GEMGlobalMember 2022-09-01 2022-09-27 0001722969 NXU:GEMGlobalMember us-gaap:CommonClassAMember 2023-09-01 2023-09-27 0001722969 NXU:WarrantLiabilityMember NXU:FirstTrancheMember 2022-11-03 0001722969 NXU:WarrantLiabilityMember NXU:FirstTrancheMember 2022-11-01 2022-11-03 0001722969 us-gaap:CommonClassAMember NXU:PurchasAgreementMember 2023-01-01 2023-01-05 0001722969 NXU:WarrantLiabilityMember NXU:SecondTrancheMember 2023-01-27 0001722969 NXU:WarrantLiabilityMember NXU:SecondTrancheMember 2023-01-01 2023-01-27 0001722969 NXU:ConvertibleNotesMember 2023-04-01 2023-04-11 0001722969 NXU:WarrantLiabilityMember NXU:ClassAOrdinarySharesMember 2023-09-30 0001722969 NXU:WarrantLiabilityMember NXU:SeriesBWarrantsMember NXU:August2023Member 2023-01-01 2023-09-30 0001722969 NXU:WarrantLiabilityMember NXU:SeriesBWarrantsMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:PurchasAgreementMember 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesAWarrantsMember 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2022-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:PurchasAgreementMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesAWarrantsMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2023-01-01 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:PurchasAgreementMember 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesAWarrantsMember 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2023-09-30 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:FirstTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:FirstTrancheMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SecondTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SecondTrancheMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesAWarrantsMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesAWarrantsMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member 2023-01-01 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member 2023-09-30 0001722969 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001722969 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-01-01 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputMaturityMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember us-gaap:MeasurementInputMaturityMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputMaturityMember 2022-01-01 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputPriceVolatilityMember 2022-01-01 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-01-01 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember 2022-12-31 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:SecondTrancheMember 2023-01-01 2023-09-30 0001722969 NXU:ConvertibleNotesMember NXU:FirstTrancheMember 2022-01-01 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputMaturityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputMaturityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputMaturityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputMaturityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputMaturityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputMaturityMember 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:PurchasAgreementMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001722969 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember NXU:GEMGlobalMember 2023-10-01 2023-10-02 0001722969 us-gaap:SubsequentEventMember NXU:CommonStockWarrantsMember NXU:GEMGlobalMember 2023-10-01 2023-10-02 0001722969 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember NXU:PublicOfferingMember 2023-10-01 2023-10-23 0001722969 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember NXU:PublicOfferingMember 2023-10-23 0001722969 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember NXU:PublicOfferingMember 2023-10-01 2023-11-23 0001722969 us-gaap:SubsequentEventMember 2023-10-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Form 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

or

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 

 

Commission file number 1-41509

 

 

 

Nxu, Inc.

(Exact name of registrant as specified in its charter)

 

 Delaware   92-2819012
(State or other jurisdiction of incorporation or organization)  

(I.R.S. Employer Identification Number)

 

1828 N. Higley Rd. Ste 116

Mesa, AZ 85205

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (760) 515-1133

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share NXU NASDAQ

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No  o

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x    No  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  o Accelerated filer  o
Non-accelerated filer  x Smaller reporting company  x
  Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.           x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  o    No  x

 

As of November 9, 2023, there were 225,430,351 and 36,075,370 shares of the Registrant’s Class A and Class B Common Stock outstanding, respectively, par value $0.0001.

 

 

   
 

 

INDEX

 

      Page
  PART I. FINANCIAL INFORMATION    
       
ITEM 1. Financial Statements   1
       
  Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 (Unaudited)   1
       
  Condensed Consolidated Statements of Operations for the Three and Nine Months Ended
September 30, 2023 and 2022 (Unaudited)
  2
       
  Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three and Nine Months Ended
September 30, 2023 and 2022 (Unaudited)
  3
       
  Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
September 30, 2023 and 2022 (Unaudited)
  5
       
  Notes to Condensed Consolidated Financial Statements (Unaudited)   6
       
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   21
       
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk   26
       
ITEM 4. Controls and Procedures   26
       
  PART II. OTHER INFORMATION    
       
ITEM 1 Legal Proceedings   27
       
ITEM 1A. Risk Factors   27
       
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds   27
       
ITEM 3 Defaults Upon Senior Securities   27
       
ITEM 4 Mine Safety Disclosures   27
       
ITEM 5 Other Information   27
       
ITEM 6. Exhibits   28
       
  Signatures   29

 

   
 

 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NXU, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands, except share data)
(Unaudited)

  

           
   September 30, 2023   December 31, 2022 
Assets          
Current Assets:          
Cash  $2,028   $2,701 
Prepaid expenses and other current assets   625    868 
Inventory       98 
Total current assets   2,653    3,667 
           
Property and equipment, net   3,141    2,441 
Intangible assets, net   9    10 
Right-of-use assets   1,709    798 
Other assets   680    122 
Total assets  8,192   $7,038 
           
Liabilities and Stockholders' Deficit          
Current Liabilities:          
Accounts payable and accrued liabilities  3,653   $3,219 
Variable share settled restricted stock units   306     
Current portion of operating lease liability   870    344 
Other current liabilities   501    680 
Total current liabilities   5,330    4,243 
           
Lease liability, net of current portion   921    558 
Convertible debt and warrant liability, at fair value   5,901    11,285 
Other long-term liabilities   300     
Total liabilities   12,452    16,086 
Commitments and contingencies (Note 11)          
           
Stockholders' deficit:          
           
Class A Common Stock, par value $0.0001; 4,000,000,000 shares authorized; 58,622,086 issued and outstanding as of September 30, 2023; 9,763,838 issued and outstanding as of December 31, 2022   6    1 
Class B Stock, par value $0.0001; 1,000,000,000 authorized; 35,175,370 issued and outstanding at September 30, 2023; 0 issued and outstanding at December 31, 2022   4    3 
Additional paid-in capital   252,318    209,564 
Accumulated deficit   (256,588)   (218,616)
Total stockholders' deficit   (4,260)   (9,048)
Total liabilities and stockholders' deficit  $8,192   $7,038 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 1 - 
 

 

NXU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except per share data)
(Unaudited)

 

                     
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
                 
Revenue  $117   $   $117   $ 
                     
Cost of revenue   1,013        1,013     
Depreciation   1        1     
Total cost of revenue   1,014        1,014     
Gross loss   (897)       (897)    
                     
Operating expenses:                    
Stock-based compensation   4,689    10,163    16,306    34,370 
Research and development   2,241    2,564    10,690    6,794 
General and administrative   4,810    1,985    12,808    7,236 
Advertising   104    1,494    284    5,131 
                     
Total operating expenses   11,844    16,206    40,088    53,531 
                     
Operating loss   (12,741)   (16,206)   (40,985)   (53,531)
                     
Other income (expense):                    
Interest expense   (33)   (5)   (73)   (5)
Paycheck protection program forgiveness               397 
Gain/(loss) on sale or disposal of property and equipment   (80)       30    (152)
Warrant expense           (984)    
Gain on convertible debt and warrant liability   1,903        4,007     
Other income       63    33    165 
                     
Total other income, net   1,790    58    3,013    405 
                     
Net loss  $(10,951)  $(16,148)  $(37,972)  $(53,126)
                     
Loss per share, basic and diluted  $(0.22)  $(2.06)  $(1.09)  $(7.22)
                     
Weighted average number of common shares outstanding used in computing loss per share:   49,101,347    7,848,640    34,875,703    7,363,248 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 2 - 
 

 

NXU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Amounts in thousands, except share data)
(Unaudited)

 

                                    
Three Months Ended September 30, 2023
   Common Stock             
   Class A   Class B   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
Balance at June 30, 2023   38,174,853   $4  -  33,825,370   $3   $246,173   $(245,637)  $543 
Common stock issued for cash   15,266,667    2            1,245        1,247 
Class B stock issued           1,350,000    1            1 
Stock-based compensation                   4,730        4,730 
Common stock issued under stock compensation plans   3,913,236                         
Exercise of Series B warrants   1,005,000                120        120 
Conversion of long term debt to equity   262,330                50        50 

Stock-based commitment fee liability (Note 12)

   

    

    

    

    

    

    

 
Net loss         -              (10,951)   (10,951)
                                    
Balance at September 30, 2023   58,622,086   $6  -  35,175,370   $4   $252,318   $(256,588)  $(4,260)

 

                                    
Nine Months Ended September 30, 2023
   Common Stock             
   Class A   Class B   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
Balance at December 31, 2022   9,763,838   $1  -  31,125,370   $3   $209,564   $(218,616)  $(9,048)
Common stock issued for cash   23,563,726    3            6,165        6,168 
Class B stock issued           4,050,000    1            1 
Stock-based compensation                   16,172        16,172 
Common stock issued under stock compensation plans   3,913,236                         
Shares issued for services   145,935                106        106 
Exercise of Series A and B warrants   6,422,100                3,420        3,420 
Exercise of stock options   77,973                547        547 
Conversion of long term debt to equity   14,735,278    2            16,344        16,346 

Stock-based commitment fee liability (Note 12)

   

    

    

    

    

    

    

 
Net loss         -              (37,972)   (37,972)
                                    
Balance at September 30, 2023   58,622,086   $6  -  35,175,370   $4   $252,318   $(256,588)  $(4,260)

 

 - 3 - 
 

 

NXU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Amounts in thousands, except share data)
(Unaudited)

 

                                              
Three Months Ended September 30, 2022
   Common Stock             
   Class A   Class C   Class B   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
                                     
Balance at June 30, 2022   7,657,322   $1       $    28,425,370   $3   $185,449   $(184,913)  $540 
Common stock issued for cash   446,815                        6,390        6,390 
Class B stock issued                   1,350,000                 
Stock-based compensation   1,434,554                        10,163        10,163 
Net loss                               (16,148)   (16,148)
                                              
Balance at September 30, 2022   9,538,691   $1       $    29,775,370   $3   $202,002   $(201,061)  $945 

 

                                              
Nine Months Ended September 30, 2022
   Common Stock             
   Class A   Class C   Class B   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
                                     
Balance at December 31, 2021   6,854,576   $1    5,000   $    25,725,370   $2   $151,734   $(147,935)  $3,802 
Common stock issued for cash   1,172,561                        15,272        15,272 
Shares issued for services and
rent guarantees
   2,000        5,000                10        10 
Class B stock issued                   4,050,000    1            1 
Exchange of class C to class A stock   75,000        (10,000)               572        572 
Stock-based compensation   1,434,554                        34,414        34,414 
Net loss                               (53,126)   (53,126)
                                              
Balance at September 30, 2022   9,538,691   $1       $    29,775,370   $3   $202,002   $(201,061)  $945 

 

 See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 4 - 
 

 

NXU, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)
(Unaudited)

 

           
   Nine Months Ended September 30, 
   2023   2022 
Cash flows from operating activities:          
Net loss  $(37,972)  $(53,126)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization   465    193 
Employee stock-based compensation   16,306    34,370 
Non-employee stock-based compensation   106    627 
Non-cash warrant expense   984     
Paycheck Protection Loan Program       (397)
Net change in operating lease assets and liabilities   (22)   (16)
Loss on write-off of inventory   896     
(Gain)/loss on the sale or disposal of property and equipment   (30)   152 
Gain on fair value of convertible debt and warrant liability   (4,007)    
Changes in assets and liabilities:          
Prepaid expenses and other current assets   243    42 
Inventory   (797)    
Other assets   (558)   (205)
Accounts payable and accrued liabilities   500    1,798 
Other current liabilities   (117)   721 
Other long-term liabilities   300     
Net cash used in operating activities   (23,703)   (15,841)
           
Cash flows from investing activities:          
Purchases of property and equipment   (1,571)   (1,394)
Proceeds from the sale of property and equipment   559    230 
Payments on financing lease liability   (77)    
Net cash used in investing activities   (1,089)   (1,164)
           
Cash flows from financing activities:          
Proceeds from public offering, net of equity offering costs   18,595    15,273 
Proceeds from the issuance of convertible debt   7,330     
Payments on convertible debt   (2,353)    
Proceeds from the exercise of stock options   547     
Net cash provided by financing activities   24,119    15,273 
Net decrease in cash   (673)   (1,732)
Cash, beginning of period   2,701    3,146 
Cash, end of period  $2,028   $1,414 
           
Supplemental disclosure of cash flow information:          
Cash paid for income taxes  $1   $5 
Interest  $1   $ 
           
Supplemental disclosure of non-cash investing and financing activities:          
Debt converted to equity  $16,464   $ 
Capital expenditures included in accounts payable and other accrued liabilities  $196   $193 
Stock-based compensation expense capitalized to property and equipment  $172   $ 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 5 - 
 

 

NXU INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1.Organization and Basis of Presentation

 

Reorganization, Merger and Incorporation of Nxu, Inc.

 

On May 12, 2023, Atlis Motor Vehicles Inc. (“Atlis”) completed its previously announced reorganization merger pursuant to the Agreement and Plan of Merger, dated as of April 16, 2023 (the “Reorganization Agreement”), by and among Atlis, Nxu, Inc., a Delaware Corporation (the “Company” or “Nxu”), and Atlis Merger Sub, Inc., a Delaware corporation and, as of immediately prior to the consummation of such merger, a wholly-owned subsidiary of Nxu (“Merger Sub”). The Reorganization Agreement provided for the merger of Atlis and Merger Sub, with Atlis surviving the merger as a wholly-owned subsidiary of Nxu (the “Reorganization Merger”). The Reorganization Agreement was approved and adopted by Atlis’s stockholders at Atlis’s Special Meeting of Stockholders, which was held on May 9, 2023.

 

The directors and executive officers of Nxu immediately following the completion of the Reorganization Merger are the same individuals who were directors and executive officers, respectively, of Atlis as of immediately prior to the Reorganization Merger.

 

Upon completion of the Reorganization Merger, Nxu Class A Common Stock was deemed to be registered under Section 12(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12g-3(a) promulgated thereunder and for purposes of Rule 12g-3(a), Nxu is the successor issuer to Atlis. Future filings by Nxu with the Securities and Exchange Commission (the “SEC”) will be filed by Nxu under Atlis’s existing CIK number: 0001722969.

 

Transactions that occurred in connection with the Reorganization Merger are considered transactions between entities under common control, and thus the financial statements for periods prior to the Reorganization Merger have been adjusted to combine the previously separate entities for presentation purpose. See more information regarding shares of common stock authorized, issued and outstanding in connection with the Reorganization Merger in Note 12 – Stock-based Compensation and Common Stock.

 

Organization

 

Nxu is a US-based technology company building megawatt (“MW”) charging stations and developing innovative battery cells and battery packs for use in advanced energy storage systems, and mobility products. The Company believes that widespread adoption of EVs by the commercial and industrial markets requires high performing battery and pack solutions that can effectively compete with legacy diesel-based products. Nxu designs, engineers, and plans to build proprietary 1 megawatt plus charging stations, lithium-ion (“Li-ion”) battery cells and packs, energy storage solutions and a suite of software and services designed to allow an easy transition from diesel to electric for our target segment.  

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements are presented on the same basis as the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission (“SEC") on March 16, 2023 (“2022 Form 10-K") pursuant to the Securities Exchange Act of 1934, as amended (“Exchange Act”). The Company has made its disclosures in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation with respect to interim financial statements, have been included. The results for any of the interim periods are not necessarily indicative of the results to be expected for the full year or any other period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto in the 2022 Form 10-K.

 

Certain amounts in the accompanying unaudited condensed consolidated financial statements and the accompanying notes may not compute due to rounding. All computations have been calculated using unrounded amounts for all periods presented. These unaudited condensed consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to fairly state, in all material respects, the Company’s financial position and results of operations for the periods presented.

  

 - 6 - 
 

 

Correction of Immaterial Misclassification

 

Management identified an immaterial classification error related to research and development costs previously reported as general and administrative expense in the June and September 30, 2022 unaudited condensed consolidated financial statements. The correction resulted in an increase to research and development costs of $1.9 million and $4.3 million for the three and nine months ended September 30, 2022, respectively, with a corresponding decrease to general and administrative expenses. The reclassification of costs allows for a more accurate presentation of research and development costs and had no impact on total operating expenses, net loss, total assets, total liabilities or shareholders’ equity (deficit).

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  

 

During the nine-month period ended September 30, 2023, the Company incurred a net loss of $38.0 million and had net cash used in operating activities of $23.7 million. As of September 30, 2023, the Company had $2.0 million in cash and an accumulated deficit of $256.6 million.

 

The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. Additionally, the Company cannot provide any assurance that access to capital will be readily available when needed. 

 

These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date these financial statements are issued. Company management is addressing this risk by pursuing all available options for funding including accessing the public markets through secondary offerings. The Company plans to continue considering all avenues available to it in order to obtain the necessary capital to be able to continue as a going concern and to execute on our business objectives including but not limited to debt financing, private placements, public offerings and equity lines of credit. The Company’s success is dependent upon achieving its strategic and financial objectives, including continuing to acquire capital through public markets as we work diligently to achieve future operational revenue goals.

 

2.Recent Accounting Pronouncements and Summary of Significant Accounting Policies

 

Recent Accounting Pronouncements

 

The Company has reviewed all recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a material impact on its consolidated financial statements.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the condensed consolidated financial statements.

 

Property, Equipment, and Software

 

Property and equipment consists of charging station equipment, leasehold improvements, other tools and equipment, and vehicles, and is stated at cost, less accumulated depreciation and amortization.

 

The Company capitalizes direct costs of materials and services consumed in developing internal-use software in accordance with ASC 350-40. The Company also capitalizes payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of software products for internal use, to the extent of the time spent directly on the project. Capitalization of costs begins during the application development stage and ends when the software is available for general use. Capitalized costs for internal-use software are amortized on a straight-line basis over the useful lives once the software is ready for intended use and is included in general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. Costs incurred during the preliminary project and post-implementation stages are charged to expense as incurred.

 

 - 7 - 
 

 

Depreciation begins when the asset is placed in service and is computed using the straight-line method over the lesser of the remaining lease term or the following estimated useful lives:

 

 
Charging station equipment 5 years
Leasehold improvements 5 years
Tools and plant equipment 5 years
Office equipment 5 years
Vehicles 5 years
Software 3 years

 

Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments are capitalized according to their estimated useful lives or over the lease term for leasehold improvements. The Company capitalizes property and equipment with an initial value over $2,500.

 

In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such facts and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. Depending on the asset, estimated fair market value may be determined either by use of the discounted cash flow model or by reference to estimated selling values of assets in similar condition.

 

Revenue Recognition

 

The company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606") following the five-step model: 1) identification of the contract, 2) identification of performance obligations, 3) determination of transaction price, 4) allocation of transaction price, and 5) recognition of revenue. The Company’s sources of revenue are primarily from retail charging services and battery systems and components sales.

 

Retail Charging Services

 

The Company provides electricity for its customers through the use of its megawatt charging station equipment. The transaction price of the charging services is set forth in the customer contracts. The Company satisfies its performance obligation at the point in time in which electricity is delivered to the customer’s vehicle. Revenue is recognized as the agreed upon purchase price, typically calculated as a dollar amount per kilowatt hour provided.

 

Battery Systems and Components

 

The Company was contracted to provide certain battery systems and components to a customer. The transaction price of the contract was set forth in the customer contract and was allocated to the separate discrete performance obligations of the contract. The company satisfied certain performance obligations at the point in time in which it delivered components to the customer and the risks and rewards of the components passed to the customer. Revenue is recognized as the cost of battery system and components as the Company did not charge a markup on the products. 

 

Cost of Revenue

 

Cost of retail charging services revenue includes the energy usage fees, maintenance and repair expenses on charging equipment, and depreciation and amortization associated with the charging station equipment.

 

Cost of battery systems and components sales include costs to acquire the components for sale to the customer and adjustments to reflect inventory at the lower of cost or net realizable value.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation (“ASC 718”). The Company classifies equity-based awards granted in exchange for services as either equity awards or liability awards. The classification of an award as either an equity award or a liability award is generally based upon cash settlement options. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period, which is the vesting period, less actual forfeitures.

 

 - 8 - 
 

 

3.Revenue

 

Prior to the three months ended September 30, 2023, the Company was in a pre-revenue development stage. In the three months ended September 30, 2023, the Company recognized the following in disaggregated revenue (in thousands):

 

     
   Three Months Ended
September 30, 2023
 
     
Battery systems and components sales  $117 
Retail charging services    
Total revenue  $117 

 

The battery system and components sales were recognized upon partial satisfaction of the performance obligations of a customer contract to produce and deliver battery systems and components. In addition, the Company recorded a contract liability in connection with the revenue not yet recognized for the remaining performance obligations of the contract. The Company subsequently determined it was unable to perform the remaining obligations, and is currently in discussions with the customer to reach a mutually negotiated settlement to resolve the remaining performance obligations enumerated in the contract. As of September 30, 2023 and December 31, 2022, the Company had a remaining contract liability under the contract of $0.41 million and $0.52 million, respectively, and is presented within other current liabilities in the accompanying unaudited condensed consolidated balance sheets.

 

On September 27, 2023, the Company also launched its first megawatt charging station to deliver electricity to customer electric vehicles. To generate customer interest, the Company offered customers significant discounts for use at the charging station, resulting in a nominal amount of revenue in the three months ended September 30, 2023.

 

4.Inventory

 

Inventory is stated at the lower of cost or net realizable value (“LCNRV”) and generally consists of raw materials and work in progress. The Company calculates inventory value on the first-in, first-out (“FIFO”) basis. NRV is the estimated selling price of inventory in the ordinary course of business, less estimated costs of completion, disposal, and transportation. The Company assesses the valuation of inventory and periodically adjusts its value for estimated excess and obsolete inventory based upon expectations of future demand and market conditions, as well as damaged or otherwise impaired goods. The following table summarizes the components of inventory in the unaudited condensed consolidated balance sheets at September 30, 2023 and December 31, 2022 (in thousands):

 

        
   September 30,
2023
   December 31, 2022 
         
Raw materials  $   $           98 
Work in process        
Total inventory  $   $98 

 

During the three months ended September 30, 2023, the Company determined it would no longer be able to complete the remaining work in process related to a customer contract for battery systems and components. As a result, the net realizable value of the inventory was $0, and the Company wrote-off approximately $0.90 million of inventory to cost of goods sold in the accompanying unaudited condensed consolidated statements of operations.

 

 - 9 - 
 

 

5.Property and Equipment

 

Property and equipment consist of the following (in thousands):

          
   September 30,
2023
   December 31, 2022 
           
Charging station equipment  $263   $ 
Leasehold improvements   151    261 
Tools and plant equipment   2,489    2,354 
Office equipment   318    114 
Software   451     
Vehicles   70    70 
Total property and equipment excluding construction in progress   3,742    2,799 
Less: accumulated depreciation and amortization   (662)   (358)
Property and equipment excluding construction in progress, net   3,080    2,441 
Charging station equipment construction in progress   61     
Property and equipment, net  $3,141   $2,441 

 

Depreciation and amortization expense was $0.16 million and $0.46 million for the three and nine months ended September 30, 2023, respectively, of which $0.16 million and $0.46 million was recorded to general and administrative expense, and a nominal amount was capitalized to cost of revenue. Depreciation and amortization expense was $0.08 million and $0.25 million for the three and nine months ended September 30, 2022, respectively, all of which was recorded to general and administrative expense.

 

6.Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consist of the following (in thousands):

          
   September 30,
2023
   December 31, 2022 
         
Tax credit receivable  $372   $ 
Prepaid insurance   54    765 
Prepaid rent       3 
Other prepaid expenses   199    100 
Total prepaid expenses and other current assets  $625   $868 

 

7.Other Assets

 

Other assets consist of the following (in thousands):

 

        
   September 30,
2023
   December 31, 2022 
         
Security deposits  $680   $101 
Vendor deposits       21 
Total prepaid expenses and other current assets  $680   $122 

 

 - 10 - 
 

 

8.Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consist of the following (in thousands):

        
   September 30,
2023
   December 31, 2022 
         
Accounts payable  $2,838   $1,523 
Accrued compensation and benefits   466    234 
Other accrued liabilities   349    1,462 
Total accounts payable and accrued liabilities  $3,653   $3,219 

 

9.Income Taxes

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company recorded a full valuation allowance due to the uncertainty of future realization of federal and state net operating loss carryforwards.

 

At December 31, 2022, the Company had net operating loss carryforwards of approximately $16.5 million which will carryforward through 2037. The Company’s fiscal year 2022 and current year net operating loss will carry forward indefinitely.

 

In December 2017, the U.S. Tax Cuts and Jobs Act of 2017 ("Tax Act") was enacted into law which significantly revised the Internal Revenue Code of 1986, as amended. The newly enacted federal income tax law, among other things, contains significant changes to corporate taxation, including a flat corporate tax rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted taxable income, limitation of the deduction for newly generated net operating losses to 80% of current year taxable income and elimination of net operating loss ("NOL") carrybacks, future taxation of certain classes of offshore earnings regardless of whether they are repatriated, immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits beginning in 2018.

 

The Company generated an income tax benefit of $9.5 million for the nine months ended September 30, 2023, resulting in a cumulative income tax benefit of $60.2 million. The Company has increased its valuation allowance accordingly as the Company's ability to generate sufficient taxable income to utilize its net operating loss carry forwards is uncertain. The Company’s deferred tax balances primarily consist of its operating loss carryforwards and stock-based compensation.

 

The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense. At September 30, 2023 and 2022 the Company did not have any unrecognized uncertain tax positions or any associated interest and penalties. 

 

10.Net Loss per Share

 

Net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period, excluding shares of Class B common stock as these shares do not participate in the earnings of the Company. For the three and nine months ended September 30, 2023 and 2022, the Company’s basic and diluted net loss per share were the same because the Company generated a net loss for each period and potentially dilutive securities are excluded from diluted net loss per share as a result of their anti-dilutive impact.

 

 - 11 - 
 

 

The following table presents the calculation of basic and diluted net loss per share during the three and nine months ended September 30, 2023 and 2022 (dollars in thousands, except per share data):

 

                
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
                 
Numerator:                    
Net loss  $(10,951)  $(16,148)  $(37,972)  $(53,126)
                     
Denominator:                    
Weighted-average shares of Class A common stock outstanding   49,101,347    7,848,640    34,875,703    7,363,248 
                     
Net loss per share, basic and diluted  $(0.22)  $(2.06)  $(1.09)  $(7.22)

 

11.Commitments and Contingencies

 

 Registration Rights

 

The holders of the convertible notes that were issued have registration rights that required the Company to register the sale of their debt securities held by them pursuant to a registration rights agreement, as amended, that was signed in conjunction with the convertible notes. 

 

Contract Losses

 

In December 2021, the Company entered into an agreement ("Agreement") with QAD, Inc. (“QAD”), a cloud-based enterprise resource software provider. Under the Agreement, QAD would facilitate implementation services and access to the cloud-based software platform for a non-cancellable, 5-year term. Subsequent to executing the Agreement, the Company determined that the software did not fit the Company’s needs and the Company and QAD (collectively, the “Parties”) were unable to successfully implement the software platform. The Parties attempted to mutually terminate the Agreement but were unsuccessful, and in May 2023, the dispute moved to arbitration to determine whether the Company owed QAD a payment for cancellation of the contract. On October 27, 2023, the Parties agreed to a settlement whereby the Company has agreed to pay a termination fee of $0.70 million to QAD over a 21-month period, upon which the Company will be released from the contract. The Company accrued the portion of the fee due within the next twelve months of $0.4 million in accounts payable and accrued liabilities, and the remaining portion within other long-term liabilities in the Company’s unaudited condensed consolidated balance sheets as of September 30, 2023.  

 

The Company is not currently subject to any other material legal proceedings, nor, to the Company’s knowledge, are any material legal proceedings threatened against the Company. From time to time, the Company may be a party to certain legal or regulatory proceedings in the ordinary course of business. While the outcome of any such future legal or regulatory proceedings cannot be predicted with certainty, management does not expect that any such future proceedings will have a material effect on the Company’s financial condition or results of operations.

 

12.Stock-based Compensation and Common Stock

 

Stock-based Compensation

 

Employees, non-employee directors and consultants of the Company participate in the 2023 Omnibus Incentive Plan (the "Plan") and are granted Nxu stock-based awards, which include restricted stock units (“RSUs”) and stock options.

 

During the three and nine months ended September 30, 2023, the Company granted RSUs that vest over various periods, ranging from immediate to increments over a period of three years. The Company has generally accounted for RSUs as liability classified awards; the awards are granted at a fixed dollar amount settled in a variable number of shares, as such, the fair value approximates the fixed dollar amount at inception. As such, the RSUs will be measured at fair value at the grant date and remeasured at the end of each reporting period until fully vested. RSUs granted and classified as equity awards are measured at fair value based on the closing price of the company’s common stock on the grant date. Compensation cost for RSUs is recognized on a straight-line basis over the requisite service period, which is the vesting period. In accordance with ASC 718-10-35-8, the amount of compensation cost recognized will at least equal the portion of the grant-date value of the award that is vested at that date.

 

 - 12 - 
 

 

Compensation expense for stock option awards was determined by applying the Black-Scholes option-pricing model on the appraised value of the underlying share price for each stock on the grant date. Calculating the fair value of stock option awards requires the input of subjective assumptions such as the expected average life of the award (in years), the expected rate of volatility, the risk free interest rate and the expected dividend yield. Other reasonable assumptions could provide differing results.

 

A summary of stock-based compensation recognized during the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands):

 

                
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
                 
Restricted stock units (classified as liabilities)  $1,751   $   $3,042   $ 
Restricted stock units (classified as equity)   758    110    1,037    410 
Stock options   2,352    10,053    12,399    33,960 
Total stock-based compensation   4,861    10,163    16,478    34,370 
Stock-based compensation capitalized to property and equipment   (172)       (172)    
Stock-based compensation, net of capitalized amount  $4,689   $10,163   $16,306   $34,370 

 

As of September 30, 2023, the total unrecognized compensation related to outstanding stock option awards and restricted stock units was $18.6 million, which the Company expects to recognize over a weighted-average period of approximately 1.0 years. Total unrecognized stock-based compensation will be adjusted for actual forfeitures.

 

2023 Omnibus Incentive Plan

 

On May 12, 2023, the Company adopted the 2023 Omnibus Incentive Plan. The purposes of the Plan are to a) encourage the growth of the Company through short and long-term incentives that are consistent with the Company’s objectives; (b) give participants an incentive for excellence in individual performance; (c) promote teamwork among participants; and (d) give the Company a significant advantage in attracting and retaining key employees, directors and consultants. To accomplish such purposes, the Plan provides that the Company may grant (i) Options, (ii) Stock Appreciation Rights, (iii) Restricted Shares, (iv) Restricted Stock Units, (v) Performance-Based Awards (including performance-based Restricted Shares and Restricted Stock Units), (vi) Other Share-Based Awards, (vii) Other Cash-Based Awards or (viii) any combination of the foregoing. The Plan was originally adopted in connection with the consummation of the Company’s Reorganization Merger as contemplated by that certain agreement and plan of merger, dated as of April 14, 2023, by and among the Company, Atlis Motor Vehicles Inc., and such other parties to the agreement.

 

With respect to awards granted under the Plan and in accordance with the Plan, the Company's Board of Directors (or the “Administrator”) is authorized to deliver an aggregate of 350 million shares of Common Stock to be reserved and available for issuance under the Plan (the “Initial Share Limit”), which includes (i) 250 million shares of Common Stock available for new issuances under the Plan and (ii) 100 million shares of Common Stock relating to a portion of outstanding stock options and restricted stock units assumed by the Company in connection with the Reorganization Merger; provided, that the total number of shares of Common Stock that will be reserved, and that may be issued, under the Plan will automatically increase on the first trading day of each calendar year, beginning with calendar year 2024, by a number of Common Shares equal to five percent (5%) of the total number of Outstanding Shares on the last day of the prior calendar year. Notwithstanding the foregoing, the Administrator may act prior to January 1 of a given year to provide that there will be no such increase in the share reserve for that year or that the increase in the share reserve for such year will be a lesser number of Common Shares than provided herein.

 

Common Stock

 

Organizational Structure

 

As described in Note 1 - Organization and Basis of Presentation, on May 12, 2023, Atlis Motor Vehicles Inc. (“Atlis”) completed its Reorganization Merger to Nxu, Inc., a Delaware Corporation (the “Company” or “Nxu”). At the effective time of the Reorganization Merger, all of the issued and outstanding shares of Atlis’s Class A common stock, par value $0.0001 per share (“Atlis Class A Common Stock”) were converted automatically on a one-for-one basis into shares of Nxu’s Class A common stock, par value $0.0001 per share (“Nxu Class A Common Stock”) and all of the issued and outstanding shares of Atlis’s Class D common stock, par value $0.0001 per share (“Atlis Class D Common Stock” and, together with Atlis Class A Common Stock, “Atlis Common Stock”) were converted automatically on a one-for-one basis into shares of Nxu’s Class B common stock, par value $0.0001 per share (“Nxu Class B Common Stock” and, together with Nxu Class A Common Stock, “Nxu Common Stock”), and, as a result, the current stockholders of Atlis automatically became stockholders of Nxu, holding the same number and percentage of shares of Nxu Common Stock as they held of Atlis Common Stock as of immediately prior to the Reorganization Merger.

 

 - 13 - 
 

 

Issuance and conversion of shares of common stock pursuant to the Reorganization Merger are considered transactions between entities under common control. As a result, the unaudited condensed consolidated financial statements for periods prior to these transactions have been adjusted to combine the previously separate entities for presentation purposes.

 

Pursuant to the Company's Reorganization Merger, each share of Atlis Motor Vehicles, Inc Class A common stock was converted into one validly issued, fully paid and nonassessable share of Nxu, Inc. Class A common stock and each share of Atlis Motor Vehicles, Inc Class D common stock was converted into one validly issued, fully paid and nonassessable share of Nxu, Inc. Class B common stock. Except as otherwise required by applicable law, and the voting rights described below, shares of Class A common stock and Class B common stock shall have the same rights, privileges and powers, rank equally, share ratably and be identical in all respects and as to all matters. The voting, dividend, liquidation and other rights, powers and preferences of the holders of Class A common stock and Class B common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock of any series as may be designated by the Board of Directors of the Corporation (the “Board”) upon any issuance of the preferred stock of any series.

 

In addition, at the effective time of the Reorganization Merger, (i) each outstanding option to purchase shares of Atlis Class A Common Stock (“Atlis Option”), whether vested or unvested, automatically converted into an option to purchase shares of Nxu Class A Common Stock (a “Nxu Option”) and (ii) each outstanding Atlis restricted share unit (an “Atlis Restricted Share”), whether vested or unvested, automatically converted into a restricted stock unit of Nxu (a “Nxu RSU”). Each Nxu Option is subject to terms and conditions consistent with the Employee Stock Option Plan and the applicable Atlis Option award agreement as in effect immediately prior to the effective time. Each Nxu RSU is subject to terms and conditions consistent with the applicable Atlis Restricted Share award agreement as in effect immediately prior to the effective time.

 

At the effective time of the Reorganization Merger, (i) each outstanding Senior Secured Original Issue 10% Discount Convertible Promissory Note (an “Atlis Note”) convertible into shares of Atlis Class A Common Stock automatically converted into a Senior Secured Original Issue 10% Discount Convertible Promissory Note convertible into shares of Nxu Class A Common Stock (a “Nxu Note”) and (ii) each outstanding warrant to purchase shares of Atlis Class A Common Stock (an “Atlis Warrant”) automatically converted into a warrant to purchase shares of Nxu Class A Common Stock (a “Nxu Warrant”). Each Nxu Note is subject to terms and conditions consistent with the applicable Atlis Note as in effect immediately prior to the effective time. Each Nxu Warrant is subject to terms and conditions consistent with the applicable Atlis Warrant as in effect immediately prior to the effective time.

 

In 2022, the Company issued Class B shares of common stock. These shares are not traded openly nor available for sale to the public. Class B shares are offered only to the (1) Chief Executive Officer and (2) President of the Company. At all meetings of stockholders and on all matters submitted to a vote of stockholders of the Corporation generally, each holder of Class A common stock, as such, shall have the right to one (1) vote per share of Class A common stock held of record by such holder and each holder of Class B common stock, as such, shall have the right to ten (10) votes per share of Class B common stock held of record by such holder. The shares of Class B common stock are not entitled to receive any dividends or any distribution upon voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. Class B shares are not convertible, are deemed to have no economic value, and upon a holder’s cessation of service to the Company, such holder shall, on the one-year anniversary of such cessation, surrender to the Company for no consideration all shares of Class B shares owned by such holder. Shares of Class B common stock were issued to the (1) Chief Executive Officer and (2) President in the amount of 31.1 million shares as of December 31, 2022.

 

Common Stock Offerings

 

On February 21, 2023, the Company completed a public offering of 8.3 million units at a public offering price of $1.56 per unit (the “February 2023 Offering”). Each unit consists of one share of Class A common stock, Series A warrants to purchase 0.65 shares of Class A common stock (the “Series A Warrants”), and Series B warrants to purchase 0.75 shares of Class A common stock (the “Series B Warrants”). See Note 13 - Convertible Notes and Warrant Liability for more information regarding the Series A and Series B warrants. Proceeds from the offering, net of offering costs, were approximately $12.0 million.

 

On August 11, 2023, the Company completed a public offering of 16.7 million units at an offering price of $0.30 per unit (the “August 2023 Offering”). Each unit consists of one share of Class A common stock (or a pre-funded warrant in lieu thereof) and one common warrant, with each warrant exercisable for two shares of Class A common stock at an exercise price of $0.30 per share (the “August 2023 Warrants). See Note 13 - Convertible Notes and Warrant Liability for more information regarding the August 2023 warrants. Proceeds from the offering, net of offering costs, were approximately $4.5 million.

 

 - 14 - 
 

 

On September 27, 2022, a stock purchase agreement between the Company and GEM Global Yield LLC SCS and GEM Yield Bahamas Limited, respectively (together, “GEM Global”) became effective whereby GEM Global committed to purchase up to $300.0 million in shares of the Company’s Class A common stock for up to three years (the “GEM Stock Purchase Facility”). In connection with the GEM Stock Purchase Facility, GEM Global would earn a commitment fee proportionate to number of shares sold in the first year, or a $6.0 million commitment fee on September 27, 2023 if no shares were sold. As of September 27, 2023, the Company had not sold any shares under the GEM Stock Purchase Facility and, as such, registered 50.0 million Class A common shares, 34.0 million of which were immediately issuable to GEM Global for payment of the commitment fee. Additionally, in connection with the share registration, approximately 0.34 million warrants were issuable to GEM Global. As the shares had not been issued to GEM Global by September 30, 2023, the Company recorded a $6.0 million commitment fee liability within stockholders’ deficit and a corresponding offset in stockholder’s deficit which will offset any future sales on the facility in the accompanying unaudited condensed consolidated balance sheets. On October 2, 2023, the 34.0 million shares of Class A common stock and 0.34 million common stock warrants were issued to GEM Global.

 

The total number of shares of all classes of capital stock which the Company has authority to issue is 5.0 billion shares, consisting of (1) 5.0 billion authorized shares of common stock, including (a) 4.0 billion authorized shares of Class A Common Stock, (b) 1.0 billion authorized shares of Class B common stock and (2) 10.0 million authorized shares of preferred stock, par value $0.0001 per share. 

 

13.Convertible Notes and Warrant Liability

 

Convertible Notes

 

On November 3, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Investors”), pursuant to which the Company agreed to issue to the Investors Senior Secured Original Issue 10% Discount Convertible Promissory Notes (“Convertible Notes” or “Notes”) and common stock warrants to purchase a number of shares of the Company’s Class A common stock equal to 30% of the face value of the Notes divided by the volume weighted average price (“VWAP”), in three tranches.

 

The Convertible Notes are convertible solely into Class A common stock of the Company at a conversion price of (a) $15 per share (“Fixed Conversion Price”) or (b) 92.5% of the average of the three lowest daily VWAP of the common stock during the ten-trading day period (“Variable Conversion Price”), whichever is lower. The Fixed Conversion Price includes a one-time reset at the 6-month anniversary of the Original Issuance Date (the “Reset Date”) to the lower of the conversion price (with the Variable Conversion Price determined as if the conversion notice was delivered on the Reset Date) and 130% of the daily VWAP of the common stock for the trading day immediately prior to the Reset Date.

 

All Convertible Notes and related common stock warrants, by written agreement, provide for a beneficial ownership limitation cap of 4.99% shares of the total issued and outstanding common stock of the Company, at any given time. Upon an event of default, the Convertible Notes earn interest at a rate of 10% per annum.

 

First Tranche

 

On November 3, 2022, the Company issued the first tranche of the Convertible Notes in the aggregate principal amount of $10.0 million and common stock warrants to purchase up to an aggregate of 231,312 shares of Class A common stock (the “First Tranche”) to the Investors pursuant to the Purchase Agreement for net proceeds of $9.0 million. These Convertible Notes have a maturity date of 24 months from the issuance date. Subsequently, upon reaching the Reset Date, the exercise price of the remaining balance was changed to $0.6403 per share. These Convertible Notes are secured by a first priority security interest in all of the assets of the Company.

 

On January 5, 2023, the Company entered into an amendment to the Purchase Agreement (the “Purchase Agreement Amendment”), pursuant to which the Company and each Investor agreed, among other things, to amend the terms and conditions of the second tranche of funding and terminate the third tranche of funding contemplated under the Purchase Agreement. In connection with the Purchase Agreement Amendment, the Company also issued a warrant to the Investors to purchase up to an aggregate of 537,960 shares of the Company’s Class A common stock (the “Purchase Agreement Amendment Tranche”).

 

Second Tranche

 

On January 27, 2023, the Investors exercised their rights to purchase the allowable amounts under the Purchase Agreement Amendment and the Company issued the second tranche of the Convertible Notes in the aggregate principal amount of $10.0 million and common stock warrants to purchase up to an aggregate of 942,034 shares of Class A common stock (the “Second Tranche”) to the Investors pursuant to the Purchase Agreement for net proceeds of $9.0 million. These Convertible Notes have a maturity date of 60 months from the issuance date. Subsequently, upon reaching the Reset Date, the exercise price of the remaining balance was changed to $0.7488 per share.

 

 - 15 - 
 

 

The Company elected the fair value option to account for the Convertible Notes, as further discussed in Note 14 – Fair Value. As such, the Company recorded the Convertible Notes at fair value and subsequently remeasures them at fair value at each reporting date. Changes in fair value are recognized as a component of other income (expense), net in the unaudited condensed consolidated statements of operations. Activity related to the Company’s Convertible Notes during the nine month period ended September 30, 2023 were as follows (in thousands):

 

     
      
  

Nine Months Ended September

30, 2023

 
     
Balance at December 31, 2022  $10,911 
Convertible Notes issued during the period   7,330 
Conversions   (16,344)
Payments   (2,353)
Change in fair value measurement   1,902 
Convertible Notes liability at September 30, 2023  $1,446 

 

Subsequent to September 30, 2023, approximately $1.2 million of the outstanding principal of the Second Tranche was converted to shares of Class A commons stock.

 

On April 11, 2023, the Company received a notice from Nasdaq indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Global Market. The Company acknowledges that receipt of the notice from Nasdaq constituted an event of default under its Convertible Notes agreements. As a result, unless waived by the holders, the Convertible Notes began accruing default interest at a rate of 10% per annum and the Company is obligated to pay to the holders $1.4 million, which amount represents 100% of the sum of (x) the outstanding principal of the Convertible Notes as of April 11, 2023 and (y) accrued and unpaid interest thereon.

 

As of September 30, 2023, the Company acknowledges the event of default had not been cured, as the Company remained out of compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Global Market. As such, a total of $0.08 million was accrued as interest payable on the Convertible Notes as of September 30, 2023.

 

Warrant Liability 

 

As discussed in previous sections of this Form 10-Q, the Company has issued warrants in connection with various capital raises. The following tables summarizes the Company’s warrants outstanding as of September 30, 2023 and December 31, 2022:

 

                              
 Warrants Outstanding                        
   First
Tranche
   Purchase
Agreement
Amendment
   Second
Tranche
   Series A   Series B   August
2023
 
                         
December 31, 2022   231,312                     
Issued       537,960    942,034    5,417,100    6,250,500    33,333,334 
Exercised               (5,417,100)   (1,005,000)    
September 30, 2023   231,312    537,960    942,034        5,245,500    33,333,334 

 

 - 16 - 
 

 

                
Common Stock
Warrants
  Issue Date  Reset Date  Exercise
Price at
Issuance
   Reset
Exercise
Price
 
First Tranche  11/3/2022  5/3/2023  $15   $0.5910 
Purchase Agreement Amendment  1/5/2023  6/5/2023  $15   $0.5825 
Second Tranche  1/27/2023  7/30/2023  $15   $0.6912 
Series A  2/21/2023  No Reset  $0    N/A 
Series B  2/21/2023  No Reset  $1.56(1)   N/A 
August 2023  8/11/2023  No Reset  $0.30(2)   N/A 

(1)  Excludes 924,750 of remaining warrants authorized to exercise for no consideration, as discussed below.
(2)Excludes pre-funded warrants, as discussed below.

 

In connection with the issuance of the Convertible Notes, the Investors received a number of common stock warrants equal to 30% of the face value of the Convertible Notes divided by the VWAP prior to the applicable closing date. The common stock warrants entitle the holder to purchase one share of the Company’s Class A common stock at the exercise price of a) $15 per share (“Exercise Price”) or (b) 92.5% of the average of the three lowest daily VWAP of the common stock during the ten-trading day period (“Variable Exercise Price”), whichever is lower. The Exercise Price included a one-time reset at the 6-month anniversary of the initial exercise date (the “Reset Date”) to the lower of the initial Exercise Price and 120% of the daily VWAP on the trading day prior to the Reset Date. The common stock warrants issued in First Tranche, Purchase Agreement Amendment Tranche, and Second Tranche have a five-year exercise period from their respective issuance date. Subsequently to their issuance, upon reaching the Reset date, the Exercise Price of these warrants was changed to $0.5910, $0.5825, and $0.6912 per share for the First Tranche, Purchase Agreement Amendment Tranche, and Second Tranche, respectively.

 

As discussed in Note 12 – Stock-based Compensation and Common Stock, in connection with the February 2023 Offering, the purchasing shareholders received Series A and Series B Warrants with each Class A common share issued. All Series A warrants were exercised following issuance for no consideration. The Series B Warrants were exercisable upon completion of the Reorganization Merger and will expire five years from the merger date.

 

As discussed in Note 12 – Stock-based Compensation and Common Stock, in connection with the August 2023 Offering, the purchasing shareholders received August 2023 Warrants with each Class A common share issued. The Company also issued pre-funded warrants (the “Pre-Funded Warrants”) which were immediately exercisable for one share of Class A common stock at an Exercise Price of $0.0001 and do not expire until exercised. The August 2023 Warrants were immediately exercisable and expire three years from the date of issuance.

 

In connection with the August 2023 Offering, the Company amended existing Series B warrant agreements to authorize certain Investors to purchase 1,929,750 shares of the Company’s Class A common stock for no consideration. As of September 30, 2023, 1,005,000 of these Series B warrants were exercised. Series B warrants are accounted for as liabilities and the fair market value of the warrants is remeasured at the end of every reporting period. As such, the change in the valuation of the liabilities as a result of the amendment to the Series B warrant agreements are reflected in the Company’s unaudited condensed consolidated balance sheets as of September 30, 2023.

 

The First Tranche, Purchase Agreement Amendment tranche, Second Tranche, Series A, Series B, and August 2023 Warrants (together, the “Common Stock Warrants”) contain a feature that precludes them from being considered indexed to the Company’s own stock and therefore are accounted for as liabilities in the Company’s unaudited condensed consolidated balance sheets. The Company records the Common Stock Warrants at fair value and subsequently remeasures unexercised warrants to fair value at the reporting date, and further discussed in Note 14 – Fair Value. Activity related to the Company’s warrants during the nine month period ended September 30, 2023 were as follows (in thousands): 

    
   September 30,
2023
 
     
Balance at December 31, 2022  $374 
Warrants issued during the period   13,410 
Warrants exercised during the period   (3,420)
Change in fair value measurement   (5,909)
Warrant liability at September 30, 2023  $4,455 

 

 - 17 - 
 

 

14.Fair Value

 

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands).

 

            
Description:  Level   September 30,
2023
   December 31, 2022 
Convertible Notes   3   $1,446   $10,911 
Warrant liability   3    4,455    374 
Convertible Notes and warrant liability, at fair value       $5,901   $11,285 

 

Convertible Notes 

 

The Company accounts for its Convertible Notes under ASC 815, Derivatives and Hedging (“ASC 815”), and as such has elected to account for the instrument under the fair value option under ASC 825. Using the fair value option, the Convertible Notes are required to be recorded at initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the notes are recognized as non-cash changes in the fair value of the Convertible Notes in other income (expense), net in the Company’s unaudited condensed consolidated statements of operations. The fair value of the conversion feature of the Convertible Notes were valued utilizing the Monte Carlo simulation model. 

 

As a result of applying the fair value option, direct costs and fees related to the Convertible Notes were expensed as incurred and were not deferred.

 

The following table provides the fair value and contractual principal balance outstanding of the Convertible Notes accounted for under the fair value option as of September 30, 2023 and December 31, 2022: 

 

          
   September 30,
2023
    December 31, 2022 
Convertible Notes fair value  $1,446   $10,911 
Convertible Notes, contractual principal outstanding   1,303    10,000 
Fair value less unpaid principal balance  $143   $911 

 

The estimated fair value of the Convertible Notes was based on the following significant inputs:  

            
   September 30, 2023   December 31,
2022
 
   First Tranche   Second Tranche   First Tranche 
             
Risk-free interest rate   5.42%   5.35%   4.46%
Time to expiration (in years)   1.09    1.26    1.84 
Expected volatility   95%   95%   85%
Dividend yield            
Stock price  $0.20   $0.20   $3.25 
Original face value  $10,000,000   $10,000,000   $10,000,000 
Fixed conversion rate  $0.64   $0.75   $15.00 
Roll-forward discount rate   6.03%   20.85%   5.11%

 

Warrant Liability 

 

 The Common Stock Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the warrants are recorded in other income (expense), net in the unaudited condensed consolidated statements of operations each period. Changes in fair value of the liability resulting from the cumulative changes in instrument-specific credit risk will be presented in accumulated other comprehensive income. As of September 30, 2023, there were no changes in the liability related to credit risk. 

 

 - 18 - 
 

 

The Common Stock Warrants are valued using a Monte Carlo simulation model, except for the Series B Warrants, which are valued using the Black Scholes simulation models, all of which are considered to be Level 3 fair value measurements. Inherent in an options pricing models are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. 

 

The following tables provide quantitative information regarding Level 3 fair value measurements for Common Stock Warrants September 30, 2023 and December 31, 2022. 

 

                            
   September 30, 2023   December 31,
2022
 
   First Tranche   Purchase
Agreement
Amendment
   Second Tranche    Series B
Warrants
    August 2023   First Tranche 
                             
Risk-free interest rate   4.60%   4.60%   4.60%     4.66    4.60%   4.46%
Time to expiration (in years)   4.09    4.26    4.26      4.40     2.86    1.84 
Expected volatility   100%   100%   100%     125%    100%   85%
Dividend yield                           
Stock price  $0.20   $0.20   $0.20    $ 0.20    $0.20   $3.25 
Exercise price  $0.59   $0.58   $0.69    $ 1.56    $0.30   $15.00 

 

15.Subsequent Events

 

Issuance of Class A Common Stock and Warrants to GEM Global

 

On October 2, 2023, the Company issued 34.0 million shares of Class A common stock and 0.34 million common stock warrants to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited, respectively (together, “GEM Global”). The issuance served as payment of a commitment fee in connection with a stock purchase agreement with GEM Global pursuant to which GEM Global committed to purchase up to $300.0 million in shares of the Company’s Class A common stock. The Company has not sold any shares under the stock purchase agreement to GEM Global under the agreement. See Note 12 – Stock-based Compensation and Common Stock for further information.

 

Nasdaq Notice

 

On October 10, 2023, the Company received a notice from Nasdaq stating that the Company did not regain compliance with the minimum bid price requirement within the 180-day period provided and is not eligible for a second 180-day period because it does not comply with the $5 million initial listing requirement for Nasdaq. As a result, Nasdaq determined that, unless the Company timely requested a hearing before the Panel, its Class A common stock would be suspended. The Company timely requested a hearing, and on October 17, 2023, it received formal notice from Nasdaq that such hearing is scheduled to be held on December 14, 2023. The delisting action has been stayed, pending a final written decision by the Panel. At the hearing, the Company will present a plan to the Panel that includes a discussion of the events that it believes will enable it to regain compliance.

 

Public Offering

 

On October 23, 2023, the Company completed a public offering of 86.0 million shares of its Class A common stock at an offering price of $0.035 per share. Proceeds from the offering, before offering costs, were approximately $3.0 million.

 

 - 19 - 
 

 

Contract Settlement

 

On October 27, 2023, the Company entered into a settlement agreement with a vendor related to a dispute over a failed software implementation. The Company has agreed to pay a $0.70 million termination fee over the next 21 months which will resolve the dispute. See Note 11 – Commitments and Contingencies for further information. 

 

August 2023 Warrants Amendments

 

On November 6, 2023, the Company and certain holders of the August 2023 Warrants agreed to amend the terms of the original warrant agreement to remove a feature that precludes the warrants from being considered indexed to the Company’s own stock. No other changes were made to the agreement.

 

 - 20 - 
 

 

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Concerning Forward-Looking Statements

 

The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates,” “could,” “may,” “estimates,” “expects,” “projects,” “intends,” “plans,” “believes,” “will” and words or phrases of similar substance used in connection with any discussion of future operations, financial performance, plans, events, trends or circumstances can be used to identify some, but not all, forward-looking statements. In particular, statements regarding expectations and opportunities, industry trends, new product expectations and capabilities, and our outlook regarding our performance and growth are forward-looking statements. This Form 10-Q also contains statements regarding plans, goals and objectives. There is no assurance that we will be able to carry out our plans or achieve our goals and objectives or that we will be able to do so successfully on a profitable basis. These forward-looking statements are just predictions and involve significant risks and uncertainties, many of which are beyond our control, and actual results may differ materially from these statements. Factors that could cause actual outcomes or results to differ materially from those reflected in forward-looking statements include, but are not limited to, those discussed in this Item 2 (including in the section entitled “Overview” below), Part II, Item 1A of this Form 10-Q, and under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 16, 2023, as amended (the “2022 Form 10-K”). Investors are urged not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date on which they were made. Except as may be required by law, we do not undertake any obligation, and expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are qualified in their entirety by the foregoing cautionary statements.

 

The following discussion of our results of operations and financial condition should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Form 10-Q and our audited consolidated financial statements and the notes thereto in the 2022 Form 10-K.

 

Our investor relations website is located at https://nxuenergy.com/investors. At or through the Investor Relations section of our website, we make available free of charge our Annual Reports on Form 10-K, other reports and all amendments to these reports as soon as practicable after the reports are electronically filed with or furnished to the SEC. Additionally, the Company uses its website, nxuenergy.com and social media channels including Instagram, YouTube, Facebook, LinkedIn, and X (formerly known as Twitter) (@Nxu) to disclose information about the company and its products to customers, investors, and the public. It's important to note that this information is not incorporated by reference in any reports or documents filed with the SEC, and website URLs are intended to be inactive textual references only. The information posted on these channels may be considered material, so investors should monitor them in addition to press releases, SEC filings, and public conference calls and webcasts. By enrolling your email address to any of our newsletters, you may receive automatic alerts and other information about Nxu.

 

Unless the context otherwise requires, the terms “we”, “us”, “our”, “Nxu” and “Company” refer to Nxu, Inc. and its consolidated subsidiaries.

 

Company Overview

  

Nxu, Inc. is a US-based technology company building energy and infrastructure solutions for consumers and businesses to enable faster transition to electrification across all market segments. We design, engineer, and build megawatt charging stations, innovative battery cells and battery packs for use in advanced energy storage systems and mobility products. We believe that widespread adoption of EVs across all market segments, especially by the commercial and industrial markets requires high performing battery and pack solutions that can effectively compete with legacy diesel-based products in terms of capability, performance and charge time.

 

On May 12, 2023, Atlis Motor Vehicles Inc. (“Atlis”) completed its previously announced reorganization merger pursuant to the Agreement and Plan of Merger, dated as of April 16, 2023 (the “Reorganization Agreement”), by and among Atlis, Nxu, Inc., a Delaware Corporation (the “Company” or “Nxu”), and Atlis Merger Sub, Inc., a Delaware corporation and, as of immediately prior to the consummation of such merger, a wholly-owned subsidiary of Nxu (“Merger Sub”). The Reorganization Agreement provided for the merger of Atlis and Merger Sub, with Atlis surviving the merger as a wholly-owned subsidiary of Nxu (the “Reorganization Merger”). The Reorganization Agreement was approved and adopted by Atlis’s stockholders at Atlis’s Special Meeting of Stockholders, which was held on May 9, 2023.

 

Nxu is an early-stage company and as such, has incurred losses from operations and have had negative cash flows from operating activities since our inception.

 

 - 21 - 
 

 

Strategic Focus on Megawatt Charging

 

In the third quarter of 2023, the Company made a strategic shift to prioritize development and deployment of our megawatt charging system. In September 2023, the Company launched the Nxu One Megawatt+ Charging System (“Nxu One”) in Mesa, Arizona and offered customers $1 charges for the first week in promotion of the product deployment.

 

In connection with the launch, we successfully demonstrated that the Nxu One differentiates itself amongst other charging units as it is the only charging system on the market capable of delivering more than 700kW of universal charging. It is designed to support up to 4.5MW of bi-directional DC power and up to 50kW of bi-directional AC power. Nxu One adapts to all vehicles that support either Tesla’s North America Charging Standard (NACS) or the Combined Charging System (CCS), charging as fast and with as much power as the vehicle will allow. Due to the fast-charging and vehicle-agnostic connection capabilities of the Nxu One, in the three days of production, we successfully delivered 1,224 kilowatt hours (“kWh”) of energy to charging customers as of September 30, 2023.

 

In connection with the shift to concentrate the Company’s resources on charging technology in 2023, Nxu paused development and production of proprietary battery cells, battery packs and related systems and components. Development and production of batteries is expected to resume in the near term.

 

Capital Funding and Cost Management

 

During the nine months ended September 30, 2023, Nxu raised approximately $26.0 million, net to fund the Company’s development, production and deployment of energy and infrastructure solutions. We continue to focus on strategic capital financing, conscientious operational spending and managing the Company’s cash position to optimize our potential for growth and profitability.

 

 Company and Industry Outlook

 

We are focused on building products to capture the commercial and industrial markets which represent a portion of the electric vehicle opportunity that we believe is not fully serviced by existing EV solutions. Individuals and companies that make up these segments require vehicles and equipment that are comparable in performance to their existing diesel-powered vehicles and equipment. However, limited battery capacity, range anxiety, and long charge times continue to be primary challenges to electrification. The Company is developing products aimed at addressing these challenges. Our planned products include our proprietary mega-watt charging infrastructure and energy storage solutions, and, in the long-term, a return to our proprietary battery cells, Qube pack technology, a modular and scalable electric powered platform, and an electric pickup truck.

   

Our strategy is to focus on execution, both in the near-term and in the long-term. Following a recent shift in focus, we are currently developing our megawatt charging station in our Mesa, AZ facility. As of September 30, 3023, we have successfully launched our first charging station as of September 2023.

 

Our operations have been financed primarily through net proceeds from the sale of securities. During the nine months ended September 30, 2023, we raised approximately $26.0 million net, after expenses, through a mix of convertible notes and S-1 Follow-on offerings. The Company intends to continue obtaining additional capital through the public markets and other means. There can be no assurance that we will obtain a sufficient level of capital through these channels in the time frames needed to sustain or grow the business or on terms agreeable to us.

 

Factors Affecting Our Performance

 

We are an early-stage company and have generated minimal revenue through the sale of our products and services. The success of our business depends on many factors. While these factors present significant opportunities for our business, they also pose risks and challenges, including those discussed in “Risk Factors” found elsewhere in this Form 10-Q, that we must successfully address to achieve growth, improve our results of operations, and generate profits.

 

·Ability to Develop, Launch, and Expand Our Products – In order to commercialize our products and services, we must test and validate them to ensure they meet the appropriate performance and safety requirements. In addition, our ability to grow and succeed in the long run will depend on our ability to successfully develop, launch, and standardize our products.
·Ability to Attract Customers – Our initial market entry and subsequent growth will depend on our ability to attract consumer and commercial customers. We are in the very early stages of customer development and an inability to build brand awareness or to attract customers would substantially impact our ability to establish revenue or improve our financial results.
·Access to Capital –In our nascent stage, we rely on the capital markets to fund our development and expected initial growth. We use this capital to fund our product development efforts, our go-to-market strategy and our business operations. Any change in our ability to successfully raise capital in the future will impact the company’s financial well-being and our ability to meet execution milestones.

 

 - 22 - 
 

 

Results of Operations

 

The following table sets forth certain statement of operations data for the three and nine-month periods ended September 30, 2023 and 2022 (dollars in thousands):

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
         
   2023  

% of
Total

operating

expenses

   2022  

% of
Total

operating

expenses

   Change   2023  

% of
Total

operating

expenses

   2022  

% of
Total

operating

expenses

   Change 
                                         
Revenue  $117    1%  $    %  $117   $117    %  $    %  $117 
                                                   
Cost of revenue   1,013    9            1,013    1,013    3            1,013 
Depreciation   1                1    1                1 
Total cost of revenue   1,014    9            1,014    1,014    3            1,014 
Gross loss   (897)   (8)           (897)   (897)   (3)           (897)
                                                   
Operating expenses                                                  
Stock-based compensation   4,689    40    10,163    63    (5,474)   16,306    41    34,370    64    (18,064)
Research and development   2,241    19    2,564    16    (323)   10,690    27    6,794    12    3,896 
General and administrative   4,810    41    1,985    12    2,825    12,808    32    7,236    14    5,572 
Advertising   104        1,494    9    (1,390)   284        5,131    10    (4,847)
                                                   
Total operating expenses   11,844    100    16,206    100    (4,362)   40,088    100    53,531    100    (13,443)
                                                   
Operating loss   (12,741)       (16,206)       3,465    (40,985)       (53,531)       12,546 
                                                   
Other income, net   1,790        58        1,732    3,013        405        2,608 
                                                   
Net loss  $(10,951)   %  $(16,148)   %  $5,197   $(37,972)   %  $(53,126)   %  $15,154 

 

Revenue

 

Three and nine months ended September 30, 2023 vs. 2022. We recognized revenue during the third quarter of 2023 of approximately $0.12 million, primarily from partial delivery of battery system and components recognized upon partial satisfaction of a customer contract. We also launched our first megawatt charging station to deliver electricity to customer electric vehicles in September 2023. To generate customer interest, we offered customers significant discounts for use at the charging station, resulting in a nominal amount of revenue in the three months ended September 30, 2023.

 

Cost of revenue

 

Three and nine months ended September 30, 2023 vs. 2022. We recognized cost of revenue during the third quarter of 2023 of approximately $1.0 million. The cost of revenue primarily represents the product cost of the battery system and components sales, along with the write-off of approximately $0.90 million in battery system and components work-in-process inventory that will not be completed or sold. We also recognized a nominal amount of energy costs and capitalized depreciation related to the charging station services.

 

Stock-based compensation 

 

Three months ended September 30, 2023 vs. 2022. Stock-based compensation decreased $5.5 million from $10.2 million during the third quarter of 2022 to $4.7 million in the third quarter of 2023 as a result of a $7.7 million decrease in the amount of options vested for employees as of September 30, 2023 compared to 2022 due to no options granted in the three months ended September 30, 2023, along with forfeitures of stock-based compensation driven by the employee terminations finalized during the three months ended September 30, 2023. The decrease was partially offset by $2.5 million compensation expense related to restricted stock units granted under the 2023 Omnibus Incentive Plan (the “Plan”). See Note 12 – Stock-based Compensation and Common Stock of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion about our stock-based compensation expense. Non-cash stock compensation expenses are expected to remain elevated in the future since it is a crucial element of our comprehensive employee compensation and management incentive plan. 

 

Nine months ended September 30, 2023 vs. 2022. Stock-based compensation decreased $18.1 million from $34.4 million during the nine months ended September 30, 2022 to $16.3 million in the nine months ended September 30, 2023 as a result of the vesting of stock options for employees and executives of $12.4 million of expense in the nine months ended September 30, 2023 compared to $34.0 million in the nine months of the prior year period. The decrease was partially offset by $4.1 million compensation expense related to restricted stock units granted under the 2023 Omnibus Incentive Plan (the “Plan”). See Note 12 – Stock-based Compensation and Common Stock of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion about our stock-based compensation expense. Non-cash stock compensation expenses are expected to remain elevated in the future since it is a crucial element of our comprehensive employee compensation and management incentive plan.

 

 - 23 - 
 

 

Research and development

 

Three months ended September 30, 2023 vs. 2022. Research and development decreased $0.32 million from $2.6 million during the third quarter of 2022 to $2.2 million in the third quarter of 2023 as we paused development and production of our battery technologies to focus on development of our megawatt charging stations. We additionally capitalized $0.59 million of research and development costs to fixed assets for our megawatt charging units completed and in process during the third quarter of 2023. We expect to continue to invest heavily in research and development as we continue to bring our products and services to market.

 

Nine months ended September 30, 2023 vs. 2022. Research and development increased $3.9 million from $6.8 million in the nine months ended September 30, 2022 to $10.7 million in the nine months ended September 30, 2023 as the Company continued battery development in the first half of the year and ramped up charging development during the nine months ended September 30, 2023. We expect to continue to invest heavily in research and development as we continue to bring our products and services to market. We also expect significant future investment in facilities, production capacity and quality, and continued refinement of our product design and development processes. As such, costs may fluctuate due to movement between R&D, finished product production, and capital expenditures.

 

General and administrative

 

Three months ended September 30, 2023 vs. 2022. General and administrative expenses increased $2.8 million from $2.0 million during the third quarter of 2022 to $4.8 million in the third quarter of 2023. The increase in general and administrative expense primarily reflects costs associated with professional services and compensation costs we incur as a public company, along with costs incurred in connection with capital offerings during the third quarter of 2023.

 

 Nine months ended September 30, 2023 vs. 2022. General and administrative expenses increased $5.6 million from $7.2 million in the nine months ended September 30, 2022 to $12.8 million in the nine months ended September 30, 2023. The increase was due to the increase in employee and labor costs from increased headcount in the first half of the 2023, along with professional services and compensation costs for outside legal counsel, accounting, and other professional services to facilitate public company activities, including for capital raises.

 

Advertising

 

Three months ended September 30, 2023 vs. 2022. Advertising decreased by $1.4 million from $1.5 million in the third quarter of 2022 to $0.10 million in the third quarter of 2023, primarily due to a substantial decrease in our marketing activities. The prior year period included expenses related to several marketing campaigns associated with our crowdfunding activities.

 

 Nine months ended September 30, 2023 vs. 2022. Advertising expense decreased by $4.8 million from $5.1 million in the nine months ended September 30, 2022 to $0.28 million in the nine months ended September 30, 2023, primarily due to our crowdfunding activities during the nine months ended September 30, 2022.

 

Other income, net

 

Three months ended September 30, 2023 vs. 2022. Other income, net increased by $1.7 million from the third quarter of 2022 to the third quarter of 2023 primarily as a result of a $1.9 million gain on the fair value of long-term debt and warrant liability. See Note 14 – Fair Value of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion.

 

Nine months ended September 30, 2023 vs. 2022. Other income, net increased by $2.6 million from the nine months ended September 30, 2022 to the nine months ended September 30, 2023 primarily as a result of $4.0 million gain on the fair value of long-term debt and warrant liability, partially offset by $1.0 million non-cash warrant expense. See Note 14 – Fair Value of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion.

 

 - 24 - 
 

 

Liquidity and Capital Resources

 

As disclosed in Note 1 – Organization and Basis of Presentation of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q, the accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. 

 

During the nine months ended September 30, 2023, the Company incurred a net loss of approximately $38.0 million and had net cash used in operating activities of $23.7 million. On September 30, 2023, the Company had $2.0 million in cash and an accumulated deficit of approximately $256.6 million.

 

During the nine months ended September 30, 2023, the Company raised capital through a combination of convertible debt and public offerings. The Company raised approximately $26.0 million in net proceeds through these avenues. The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. 

 

Because our working capital requirements depend upon numerous factors, there can be no assurance that our current cash resources will be sufficient to fund our operations. Thus, we will require immediate additional financing to fund future operations. There can be no assurance, however, that we will be able to obtain funds on acceptable terms, if at all. 

 

These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date these financial statements are issued. Company management is addressing this risk by pursuing all available options for funding including accessing the public markets. The Company plans to continue considering all avenues available to it in order to obtain the necessary capital to be able to continue as a going concern and to execute on our business objectives including but not limited to debt financing, private placements, public offerings and equity lines of credit. The Company’s success is dependent upon achieving its strategic and financial objectives, including continuing to acquire capital through public markets.

 

The table below sets forth a summary of our cash flows for the nine months ended September 30, 2023 and 2022 (in thousands):

 

   Nine Months Ended
September 30,
 
   2023   2022 
         
Net cash used in operating activities  $(23,705)  $(15,841)
Net cash used in investing activities   (1,089)   (1,164)
Net cash provided by financing activities   24,121    15,273 

 

Net cash used in operating activities. Net cash used in operating activities during the nine months ended September 30, 2023 was $23.7 million. The use of cash resulted primarily from a net loss of $38.0 million, including the $4.0 million change in the fair value of convertible debt and warrant liability, partially offset by employee and non-employee stock-based compensation expense of $16.3 million.

 

Net cash used in operating activities during the nine months ended September 30, 2022 of $15.8 million resulted primarily from a net loss of $53.1 million, offset by non-cash employee and non-employee stock-based compensation expense of $35.0 million and changes in working capital.

 

Net cash used in investing activities. Net cash used in investing activities for the nine months ended September 30, 2023 and 2022, was $1.1 million and $1.2 million, respectively. The cash used in investing activities was related to purchases of property and equipment during each period, and was partially offset by cash provided by investing activities was related to the sale of production equipment.

 

Net cash provided by financing activities. Net cash provided by financing activities of $24.1 million during the nine months ended September 30, 2023 primarily consisted of proceeds from stock and convertible debt issuances, offset by partial cash payments on convertible debt.

 

Net cash provided by financing activities of $15.3 million during the nine months ended September 30, 2022 primarily consisted of proceeds from stock issuance from the Company’s Regulation A+ offering and crowd funding campaigns.

 

We have contractual lease obligations for our facilities with initial terms between two and five years. One of the agreements includes up to one or more options to renew with renewal terms that can extend the lease term by five years or more. In addition, we have obligations under our convertible debt facility to repay the remaining balance not converted into equity at the maturity date two years from issuance. See Note 13 - Convertible Notes and Warrant Liability of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion.

 

 - 25 - 
 

 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable.

 

Item 4.  Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security Exchange Act of 1934, as amended, the “Exchange Act”) as of September 30, 2023, the end of the period covered by this Form 10-Q (the “Evaluation Date”). They have concluded that, as of the Evaluation Date, these disclosure controls and procedures were effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities and would be disclosed on a timely basis. The Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are designed, and are effective, to give reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the rules and forms of the SEC. They have also concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. 

 

Changes in Internal Control over Financial Reporting

 

During the quarter ended September 30, 2023, there were no changes in our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 - 26 - 
 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

See Note 11 – Commitments and Contingencies of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in the section entitled “Risk Factors,” in the 2022 Form 10-K, which could materially affect our business, financial condition, or future results. As of the date of this Form 10-Q, there have been no material changes to the risk factors disclosed in the section entitled “Risk Factors” in our 2022 Form 10-K other than as set forth below: 

 

Our Class A common stock may be delisted from Nasdaq if we do not maintain compliance with Nasdaqs continued listing requirements. If our Class A common stock is delisted, it could negatively impact the Company. 

 

Continued listing of a security on Nasdaq is conditioned upon compliance with various continued listing standards. On April 11, 2023, we received a notice from Nasdaq stating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the “Bid Price Requirement”). On August 29, 2023, we received an additional notice from Nasdaq stating that the Company’s reported stockholders’ equity no longer meets the minimum stockholders’ equity of $2.5 million required for continued listing of the Company’s Class A common stock on Nasdaq under Nasdaq Listing Rule 5550(b)(1).

 

On October 10, 2023, we received a notice from Nasdaq stating that we did not regain compliance with the minimum bid price requirement within the 180-day period provided and are not eligible for a second 180-day period because we do not comply with the $5 million initial listing requirement for Nasdaq. As a result, Nasdaq determined that, unless we timely requested a hearing before the Panel, our Class A common stock would be suspended. We timely requested a hearing, and on October 17, 2023, we received formal notice from Nasdaq that such hearing is scheduled to be held on December 14, 2023. The delisting action has been stayed, pending a final written decision by the Panel. At the hearing, we will present a plan to the Panel that includes a discussion of the events that we believe will enable us to regain compliance.

 

No assurances can be provided that Nasdaq will overturn the delisting determination, even if we regain compliance with the minimum bid price requirement within the appeal period. If the Company’s Class A common stock ultimately were to be delisted for any reason, it could negatively impact the Company by (i) reducing the liquidity and market price of the Company’s Class A common stock; (ii) reducing the number of investors willing to hold or acquire the Company’s Class A common stock, which could negatively impact the Company’s ability to raise equity financing; (iii) limiting the Company’s ability to use a registration statement to offer and sell freely tradable securities, thereby preventing the Company from accessing the public capital markets; and (iv) impairing the Company’s ability to provide equity incentives to its employees. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 

 

 None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

 - 27 - 
 

 

Item 6. Exhibits  

 

Exhibit No.  Exhibit Description 
4.1  Form of Warrant Agreement (incorporated by reference to Exhibit 4.1 of the Registration Statement on Form S-1/A filed with the SEC on August 4, 2023)
   
4.2  Form of Pre-Funded Warrant Agreement (incorporated by reference to Exhibit 4.2 of the Registration Statement on Form S-1/A filed with the SEC on August 4, 2023)
   
10.1  Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Registration Statement on Form S-1 filed with the SEC on August 8, 2023)
   
10.2  Letter Agreement Relating to Share Subscription Facility, dated as of September 19, 2023, among the Company, GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (incorporated by reference to Exhibit 10.16 of the Registration Statement on Form S-1 filed with the SEC on September 19, 2023)
   
31.1  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d - 14(a)
     
31.2  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d - 14(a)
     
32.1*  Certification of Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS  Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. 
     
101.SCH  Inline XBRL Taxonomy Extension Schema Document 
     
101.CAL  Inline XBRL Taxonomy Extension Calculation Linkbase Document 
     
101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase Document 
     
101.LAB  Inline XBRL Taxonomy Extension Label Linkbase Document 
     
101.PRE  Inline XBRL Taxonomy Extension Presentation Linkbase Document 
     
104  Cover Page Interactive Data File (embedded within the Inline XBRL document) 

 

*Furnished herewith. This exhibit should not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

 - 28 - 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  Nxu, Inc.
     
     
Date: November 10, 2023 By:    /s/ Apoorv Dwivedi
    Apoorv Dwivedi
    Chief Financial Officer
    (Principal Financial Officer)

 

 

- 29 -

 

 

 

 

Exhibit 31.1

 

Certification of Principal Executive Officer Required by

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended,

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, Mark Hanchett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Nxu, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 Date: November 10, 2023 By: /s/ Mark Hanchett  
  Mark Hanchett  
  Chief Executive Officer  

 

 

 

 

 

 

 

Exhibit 31.2

 

Certification of Principal Financial Officer Required by

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended,

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, Apoorv Dwivedi, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Nxu, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

Date: November 10, 2023 By: /s/ Apoorv Dwivedi  
  Apoorv Dwivedi  
  Chief Financial Officer  

 

 

 

 

 

 

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Nxu, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

 

Date: November 10, 2023 By: /s/ Mark Hanchett  
  Mark Hanchett  
  Chief Executive Officer  
     

 

 

Date: November 10, 2023 By: /s/ Apoorv Dwivedi  
  Apoorv Dwivedi  
  Chief Financial Officer  
     

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.